IQVIA 

$178.18
131
-$3.28-1.81% 今天

統計

當日最高
183.34
當日最低
177.24
52週高點
247.05
52週低點
153.01
成交量
169,321,139
平均成交量
-
市值
30.24B
本益比
22.51
股息殖利率
-
股息
-

即將到來

財報

28Jul預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
下一步
2.63
2.9
3.16
3.42
預期EPS
3.038327
實際EPS
不適用

財務

8.34%利潤率
有盈利
2020
2021
2022
2023
2024
2025
32.62B營收
2.72B淨利

分析師評級

221.40平均目標價
最高預估為 255.00。
來自過去6個月內的 10 則評分。這不是投資建議。
買入
90%
持有
10%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 IQV 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Show more...
執行長
Mr. Ari Bousbib
員工
89000
國家
美國
ISIN
US46266C1053

上市

0 Comments

分享你的想法

FAQ

IQVIA 今天的股價是多少?
IQV 目前價格為 $178.18 USD,過去 24 小時下跌了 -1.81%。在圖表上更密切關注 IQVIA 股票的表現。
IQVIA 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,IQVIA 的股票以代號 IQV 進行交易。
IQVIA 的股價在上漲嗎?
IQV 股票較上週下跌 -2.92%,本月上漲 +5.44%,過去一年 IQVIA 上漲 +13.66%。
IQVIA 的市值是多少?
今天 IQVIA 的市值為 30.24B
IQVIA 下一次財報日期是什麼時候?
IQVIA 將於 July 28, 2026 公布下一次財報。
IQVIA 上一季度的財報如何?
IQV 上一季度的財報為每股 2.9 USD,預估為 2.82 USD,帶來 +2.97% 的驚喜。下一季度的預估財報為每股 不適用 USD。
IQVIA 去年的營收是多少?
IQVIA 去年的營收為 32.62BUSD。
IQVIA 去年的淨利是多少?
IQV 去年的淨收益為 2.72BUSD。
IQVIA 有多少名員工?
截至 June 15, 2026,公司共有 89,000 名員工。
IQVIA 位於哪個產業?
IQVIA從事於Health & Wellness產業。
IQVIA 何時完成拆股?
IQVIA 最近沒有進行任何拆股。
IQVIA 的總部在哪裡?
IQVIA 的總部位於 美國 的 Durham。